Scribd Logo
Upload

Welcome to Scribd!

  • 11 views

    Ilaç Raporu

    Uploaded by

    M. K.
    The patient had their 10th session of neurological rehabilitation treatment which included respiratory exercises, strength training, and passive joint movement. They were discharged at their family's request. The patient was prescribed Osmolak 667 mg/ml 250 ml solution and Enox 6000 anti-XA iu/0.6 ml injector during this time for their treatment. Follow up was recommended at the polyclinic.

    Copyright:

    © All Rights Reserved
    Download as DOCX, PDF, TXT or read online from Scribd
    Flag for inappropriate content

    You might also like

    Ilaç Raporu

    Uploaded by

    M. K.
    11 views1 page
    The patient had their 10th session of neurological rehabilitation treatment which included respiratory exercises, strength training, and passive joint movement. They were discharged at their family's request. The patient was prescribed Osmolak 667 mg/ml 250 ml solution and Enox 6000 anti-XA iu/0.6 ml injector during this time for their treatment. Follow up was recommended at the polyclinic.

    Original Description:

    Original Title

    ilaç raporu

    Copyright

    © © All Rights Reserved

    Available Formats

    DOCX, PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Report this Document
    The patient had their 10th session of neurological rehabilitation treatment which included respiratory exercises, strength training, and passive joint movement. They were discharged at their family's request. The patient was prescribed Osmolak 667 mg/ml 250 ml solution and Enox 6000 anti-XA iu/0.6 ml injector during this time for their treatment. Follow up was recommended at the polyclinic.

    Copyright:

    © All Rights Reserved
    Download as DOCX, PDF, TXT or read online from Scribd
    Flag for inappropriate content
    Download as docx, pdf, or txt
    11 views1 page

    Ilaç Raporu

    Uploaded by

    M. K.
    The patient had their 10th session of neurological rehabilitation treatment which included respiratory exercises, strength training, and passive joint movement. They were discharged at their family's request. The patient was prescribed Osmolak 667 mg/ml 250 ml solution and Enox 6000 anti-XA iu/0.6 ml injector during this time for their treatment. Follow up was recommended at the polyclinic.

    Copyright:

    © All Rights Reserved
    Download as DOCX, PDF, TXT or read online from Scribd
    Flag for inappropriate content
    Download as docx, pdf, or txt
    of 1

    Package Transactions

    Clinical Progress
    9.07.2021
    22.07.2021 P915033 Physical therapy and rehabilitation Group A
    10.07.2021 P915033 Physical therapy and rehabilitation Group A
    12.07.2021
    HOLIDAY P915033 Physical therapy and rehabilitation Group A
    13.07.2021 P915033
    ENOX 6000 ANTI-XA Physical
    IU/0.6 therapy and
    ML READY-TO-USE rehabilitation
    INJECTOR 1 Group A
    14.07.2021
    OSMOLAK 667 P915033
    MG/ML 250Physical therapy
    ML SOLUTION (25and rehabilitation
    SCALE) 2 Group A
    23.07.2021 P915033 Physical therapy and rehabilitation Group A
    15.07.2021
    16.07.2021 P915033 Physical therapy and rehabilitation Group A
    HOLIDAY
    17.07.2021 P915033 Physical therapy and rehabilitation Group A
    ENOX 6000 ANTI-XA IU/0.6 ML READY-TO-USE INJECTOR 1
    19.07.2021
    OSMOLAK 667 P915033
    MG/ML 250Physical therapy
    ML SOLUTION (25and rehabilitation
    SCALE) 3 Group A
    24.07.2021
    24.07.2021 P915033 Physical therapy and rehabilitation Group A
    Medications Used
    THE PATIENT HAS THE 10TH SESSION OF NEUROLOGICAL REHABILITATION TREATMENT
    RESPIRATORY
    Date Name EXERCISES, PROGRESSIVE RESISTIVE STRENGTHENING
    Quantity EXERCISEName
    Date FOR BOTH UPPER Quantity
    EXTREMITY, , BOTH
    PASSIVE JOINT MOVEMENT FOR LOWER EXTREMITY EXERCISE, STRESS FOR ANKLES, ELECTRIC
    10.07.2021 OSMOLAK
    STUMILATION 667 MG/ML
    WAS APPLIED TO250
    THEML SOLUTION
    EXTENT THAT(25 1
    IT CAN TOLERATE, 10.07.2021
    IN-BED ENOX 6000 ANTİ-XA IU/0.6 ML USAGE
    TILT EXHAUST 1
    ENOX 6000 ANTI-XA IU/0.6 ML READY-TO-USE INJECTOR 1
    OSMOLAK 667 MG/ML 250 ML SOLUTION (25 SCALE) 3
    10.07.2021 OSMOLAK
    IT WAS DECIDED TO 667 MG/ML 250
    DISCHARGE MLPATIENT
    THE SOLUTION (25THE PATIENT'S
    AND 1 10.07.2021
    RELATIVES OSMOLAK
    AT THE 667 MG/ML 250 ML SOLUTION (
    REQUEST. 1
    FURTHER, POLYCLINIC CONTROL WAS RECOMMENDED.
    11.07.2021 OSMOLAK 667 MG/ML 250 ML SOLUTION (25 1 11.07.2021 ENOX 6000 ANTI-XA IU/0.6 ML USAGE 1

    12.07.2021 OSMOLAK 667 MG/ML 250 ML SOLUTION (25 3 12.07.2021 ENOX 6000 ANTI-XA IU/0.6 ML USAGE 1

    12.07.2021 OSMOLAK 667 MG/ML 250 ML SOLUTION (25 1 12.07.2021 OSMOLAK 667 MG/ML 250 ML SOLUTION ( 3

    13.07.2021 OSMOLAK 667 MG/ML 250 ML SOLUTION (25 3 13.07.2021 ENOX 6000 ANTI-XA IU/0.6 ML USAGE 1

    13.07.2021 OSMOLAK 667 MG/ML 250 ML SOLUTION (25 1 13.07.2021 OSMOLAK 667 MG/ML 250 ML SOLUTION ( 3

    14.07.2021 OSMOLAK 667 MG/ML 250 ML SOLUTION (25 3 14.07.2021 ENOX 6000 ANTI-XA IU/0.6 ML USAGE 1

    14.07.2021 OSMOLAK 667 MG/ML 250 ML SOLUTION (25 1 14.07.2021 OSMOLAK 667 MG/ML 250 ML SOLUTION ( 1

    15.07.2021 OSMOLAK 667 MG/ML 250 ML SOLUTION (25 1 15.07.2021 ENOX 6000 ANTI-XA IU/0.6 ML USAGE 1

    15.07.2021 OSMOLAK 667 MG/ML 250 ML SOLUTION (25 1 15.07.2021 OSMOLAK 667 MG/ML 250 ML SOLUTION ( 1

    16.07.2021 OSMOLAK 667 MG/ML 250 ML SOLUTION (25 1 16.07.2021 ENOX 6000 ANTI-XA IU/0.6 ML USAGE 1

    16.07.2021 OSMOLAK 667 MG/ML 250 ML SOLUTION (25 1 16.07.2021 OSMOLAK 667 MG/ML 250 ML SOLUTION ( 3

    17.07.2021 OSMOLAK 667 MG/ML 250 ML SOLUTION (25 1 17.07.2021 ENOX 6000 ANTI-XA IU/0.6 ML USAGE 1

    EPICRISIS REPORT

    You might also like